[Metastatic pancreatic neuroendocrine tumors and chemotherapy: evidences and perspectives].
Gómez Raposo
César
C
Gómez Senent
Silvia
S
González Barón
Manuel
M
D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D019468:Disease Management; D004317:Doxorubicin / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage; D018358:Neuroendocrine Tumors / Q000188:drug therapy / Q000556:secondary*; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011868:Radioisotopes / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013311:Streptozocin / Q000008:administration & dosage; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D016898:Interferon-alpha; D009944:Organoplatinum Compounds; D011868:Radioisotopes; D013311:Streptozocin; D004317:Doxorubicin; D005472:Fluorouracil